Year |
Citation |
Score |
2018 |
Park HW, Kang MG, Kim K, Koh JS, Park JR, Jeong YH, Ahn JH, Jang JY, Kwak CH, Park Y, Jeong MH, Kim YJ, Cho MC, Kim CJ, Hwang JY, et al. Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry. Korean Circulation Journal. 48: 134-147. PMID 29441746 DOI: 10.4070/kcj.2017.0174 |
0.309 |
|
2017 |
Lee KS, Lee K, Yun S, Moon S, Park Y, Han JH, Kim CY, Lee HS, Choe G. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma. Journal of Neuro-Oncology. PMID 29147863 DOI: 10.1007/s11060-017-2675-6 |
0.306 |
|
2017 |
Kwon O, Joung J, Park Y, Kim CW, Hong SH. Considerations of critical quality attributes in the analytical comparability assessment of biosimilar products. Biologicals : Journal of the International Association of Biological Standardization. PMID 28495312 DOI: 10.1016/j.biologicals.2017.04.005 |
0.308 |
|
2017 |
Kang HK, Kim C, Seo CH, Park Y. The therapeutic applications of antimicrobial peptides (AMPs): a patent review. Journal of Microbiology (Seoul, Korea). 55: 1-12. PMID 28035594 DOI: 10.1007/s12275-017-6452-1 |
0.307 |
|
2016 |
Kang SW, Patnaik BB, Hwang HJ, Park SY, Chung JM, Song DK, Patnaik HH, Lee JB, Kim C, Kim S, Park YS, Park HS, Park SH, Han YS, Lee JS, et al. Sequencing and de novo assembly of visceral mass transcriptome of the critically endangered land snail Satsuma myomphala: Annotation and SSR discovery. Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics. 21: 77-89. PMID 28107688 DOI: 10.1016/j.cbd.2016.10.004 |
0.308 |
|
2016 |
Kim MJ, Kim CS, Park YS, Choi EH, Han KD. The Efficacy of Intraoperative Frozen Section Analysis During Breast-Conserving Surgery for Patients with Ductal Carcinoma In Situ. Breast Cancer : Basic and Clinical Research. 10: 205-210. PMID 27980416 DOI: 10.4137/BCBCR.S40868 |
0.311 |
|
2014 |
Oh SY, Hwang IG, Lee J, Park MJ, Lee S, Kim S, Song K, Son CH, Kang JH, Kang MH, Kim HG, Park YS, Sun J, Kim HJ, Kim CK, et al. 1339PDPHASE II TRIAL OF EPIDERMAL GROWTH FACTOR OINTMENT FOR PATIENTS WITH ERLOTINIB-RELATED SKIN EFFECTS. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv471-iv472. PMID 28174880 DOI: 10.1093/annonc/mdu350.3 |
0.303 |
|
Show low-probability matches. |